|
MXPA06001002A
(es)
*
|
2003-07-25 |
2006-04-11 |
Amgen Inc |
Piridonas y pirimidinonas sustituidas con propiedades antiinflamatorias.
|
|
CA2535644A1
(en)
|
2003-08-20 |
2005-03-03 |
Amgen Inc. |
Substituted pyrimdinone derivatives and methods of use
|
|
NZ556017A
(en)
*
|
2004-12-24 |
2009-10-30 |
Prosidion Ltd |
G-protein coupled receptor (gpr116) agonists and use thereof for treating obesity and diabetes
|
|
AR059898A1
(es)
|
2006-03-15 |
2008-05-07 |
Janssen Pharmaceutica Nv |
Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
|
|
US7528448B2
(en)
*
|
2006-07-17 |
2009-05-05 |
E.I. Du Pont De Nemours And Company |
Thin film transistor comprising novel conductor and dielectric compositions
|
|
US8062824B2
(en)
|
2006-07-17 |
2011-11-22 |
E. I. Du Pont De Nemours And Company |
Thermally imageable dielectric layers, thermal transfer donors and receivers
|
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
|
SI2203439T1
(sl)
|
2007-09-14 |
2011-05-31 |
Ortho Mcneil Janssen Pharm |
1',3'-disubstituirani 4-fenil-3,4,5,6-tetrahidro-2H-1'H-(1,4')bipiridinil-2'-oni
|
|
US7666567B2
(en)
|
2007-10-23 |
2010-02-23 |
E. I. Du Pont De Nemours And Company |
Negative imaging method for providing a patterned metal layer having high conductivity
|
|
US7666568B2
(en)
*
|
2007-10-23 |
2010-02-23 |
E. I. Du Pont De Nemours And Company |
Composition and method for providing a patterned metal layer having high conductivity
|
|
ES2439291T3
(es)
|
2008-09-02 |
2014-01-22 |
Janssen Pharmaceuticals, Inc. |
Derivados de 3-azabiciclo[3.1.0]hexilo como moduladores de receptores de glutamato metabotrópicos
|
|
ES2401691T3
(es)
|
2008-11-28 |
2013-04-23 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
Derivados de indol y de benzoxacina como moduladores de los receptores metabotrópicos de glutamato
|
|
SG176018A1
(en)
|
2009-05-12 |
2011-12-29 |
Janssen Pharmaceuticals Inc |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
ES2440001T3
(es)
|
2009-05-12 |
2014-01-27 |
Janssen Pharmaceuticals, Inc. |
Derivados de 1,2,4-triazolo[4,3-A]piridina y su uso para el tratamiento o prevención de trastornos neurológicos y psiquiátricos
|
|
CA2814998C
(en)
|
2010-11-08 |
2019-10-29 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
CN103298809B
(zh)
|
2010-11-08 |
2016-08-31 |
杨森制药公司 |
1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
|
|
ES2552455T3
(es)
|
2010-11-08 |
2015-11-30 |
Janssen Pharmaceuticals, Inc. |
Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
|
|
US9133187B2
(en)
|
2011-02-28 |
2015-09-15 |
Array Biopharma Inc. |
Serine/threonine kinase inhibitors
|
|
KR101979042B1
(ko)
|
2011-08-04 |
2019-05-15 |
어레이 바이오파마 인크. |
세린/트레오닌 키나제 억제제로서의 퀴나졸린 화합물
|
|
WO2013066729A1
(en)
*
|
2011-10-31 |
2013-05-10 |
Merck Sharp & Dohme Corp. |
Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
|
|
US10531655B2
(en)
|
2011-12-02 |
2020-01-14 |
The Regents Of The University Of California |
Reperfusion protection solution and uses thereof
|
|
DK3321262T3
(da)
|
2012-03-01 |
2021-01-25 |
Array Biopharma Inc |
Serin-/threoninkinasehæmmere
|
|
JP6378182B2
(ja)
|
2012-08-27 |
2018-08-22 |
アレイ バイオファーマ、インコーポレイテッド |
過剰増殖性│疾患の処置のためのセリン/スレオニンキナーゼ阻害剤
|
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
|
US10537573B2
(en)
|
2014-01-21 |
2020-01-21 |
Janssen Pharmaceutica Nv |
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
|
|
IL279202B2
(en)
|
2014-01-21 |
2023-09-01 |
Janssen Pharmaceutica Nv |
Combinations containing positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic subtype 2 receptor and their use
|
|
US11178870B2
(en)
*
|
2017-04-11 |
2021-11-23 |
Mitsui Chemicals Agro, Inc. |
Pyridone compounds and agricultural and horticultural fungicides containing the same as active ingredients
|
|
IL302293A
(en)
*
|
2017-08-23 |
2023-06-01 |
Sprint Bioscience Ab |
Pyridinamine-pyridone and pyrimidinamine-pyridone compounds
|
|
EP4056556A1
(en)
*
|
2017-08-23 |
2022-09-14 |
Sprint Bioscience AB |
Pyridylpyridone compounds
|
|
US12479816B2
(en)
|
2019-02-08 |
2025-11-25 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
20-HETE formation inhibitors
|
|
CA3199988A1
(en)
|
2020-11-25 |
2022-06-02 |
Daniel L. Flynn |
Pyridylpyridone derivatives as vsp34 inhibitors for use in the treatment of a viral infection
|
|
WO2023156386A2
(en)
*
|
2022-02-16 |
2023-08-24 |
Duke Street Bio Limited |
Pharmaceutical compound
|
|
CN120379982A
(zh)
|
2022-12-02 |
2025-07-25 |
纽摩拉治疗公司 |
治疗神经障碍的方法
|